Overall survival in the UK in mycosis fungoides or S ´ ezary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care
Aim: Due to extensive treatment switching in the MAVORIC trial, lack of UK regulatory licence for the comparator, overall survival (OS) with mogamulizumab was compared with patients with previously treated advanced mycosis fungoides/S ´ ezary syndrome (MF/SS) in real-world setting. Design, setting...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Becaris Publishing Limited
2023-08-01
|
| Series: | Journal of Comparative Effectiveness Research |
| Subjects: |